Drugs / DPX-0907
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01095848 | Mar 2010 → Apr 2011 | breast neoplasm, ovarian neoplasm, prostate neoplasm | ImmunoVaccine Technologies, Inc. (IMV Inc.) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPX-0907 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01095848 ↗ |
| Modality | Vaccine | “therapeutic cancer vaccine, DPX-0907” PMID 22862954 ↗ Aug 2012 |
| Route | Subcutaneous | “subcutaneous injections” NCT01095848 ↗ |